Literature DB >> 34014982

Pre-intervention characteristics of the mosquito species in Benin in preparation for a randomized controlled trial assessing the efficacy of dual active-ingredient long-lasting insecticidal nets for controlling insecticide-resistant malaria vectors.

Boulais Yovogan1,2, Arthur Sovi2,3,4, Gil G Padonou1,2, Constantin J Adoha1,2, Bruno Akinro2, Saïd Chitou2, Manfred Accrombessi4,5, Edouard Dangbénon2, Hilaire Akpovi2, Louisa A Messenger4,6, Razaki Ossè2,7, Aurore Ogouyemi Hounto8,9, Jackie Cook10, Immo Kleinschmidt10,11,12, Corine Ngufor2,4, Mark Rowland4, Natacha Protopopoff4, Martin C Akogbéto2.   

Abstract

BACKGROUND: This study provides detailed characteristics of vector populations in preparation for a three-arm cluster randomized controlled trial (RCT) aiming to compare the community impact of dual active-ingredient (AI) long-lasting insecticidal nets (LLINs) that combine two novel insecticide classes-chlorfenapyr or pyriproxifen-with alpha-cypermethrin to improve the prevention of malaria transmitted by insecticide-resistant vectors compared to standard pyrethroid LLINs.
METHODS: The study was carried out in 60 villages across Cove, Zangnanando and Ouinhi districts, southern Benin. Mosquito collections were performed using human landing catches (HLCs). After morphological identification, a sub-sample of Anopheles gambiae s.l. were dissected for parity, analyzed by PCR for species and presence of L1014F kdr mutation and by ELISA-CSP to identify Plasmodium falciparum sporozoite infection. WHO susceptibility tube tests were performed by exposing adult An. gambiae s.l., collected as larvae from each district, to 0.05% alphacypermethrin, 0.75% permethrin, 0.1% bendiocarb and 0.25% pirimiphos-methyl. Synergist assays were also conducted with exposure first to 4% PBO followed by alpha-cypermethrin.
RESULTS: An. gambiae s.l. (n = 10807) was the main malaria vector complex found followed by Anopheles funestus s.l. (n = 397) and Anopheles nili (n = 82). An. gambiae s.l. was comprised of An. coluzzii (53.9%) and An. gambiae s.s. (46.1%), both displaying a frequency of the L1014F kdr mutation >80%. Although more than 80% of people slept under standard LLIN, human biting rate (HBR) in An. gambiae s.l. was higher indoors [26.5 bite/person/night (95% CI: 25.2-27.9)] than outdoors [18.5 b/p/n (95% CI: 17.4-19.6)], as were the trends for sporozoite rate (SR) [2.9% (95% CI: 1.7-4.8) vs 1.8% (95% CI: 0.6-3.8)] and entomological inoculation rate (EIR) [21.6 infected bites/person/month (95% CI: 20.4-22.8) vs 5.4 (95% CI: 4.8-6.0)]. Parous rate was 81.6% (95%CI: 75.4-88.4). An. gambiae s.l. was resistant to alpha-cypermethrin and permethrin but, fully susceptible to bendiocarb and pirimiphos-methyl. PBO pre-exposure followed by alpha-cypermethrin treatment induced a higher 24 hours mortality compared to alphacypermethrin alone but not exceeding 40%.
CONCLUSIONS: Despite a high usage of standard pyrethroid LLINs, the study area is characterized by intense malaria transmission. The main vectors An. coluzzii and An. gambiae s.s. were both highly resistant to pyrethroids and displayed multiple resistance mechanisms, L1014F kdr mutation and mixed function oxidases. These conditions of the study area make it an appropriate site to conduct the trial that aims to assess the effect of novel dual-AI LLINs on malaria transmitted by insecticide-resistant vectors.

Entities:  

Mesh:

Year:  2021        PMID: 34014982      PMCID: PMC8136630          DOI: 10.1371/journal.pone.0251742

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Background

Malaria remains a major public health issue in Benin, with prevalence of infection within the general population ranging from 11% to 51% depending on the region, with high burden in children under 5 years old [1]. Long-lasting insecticidal nets (LLINs) distributed at the national level every three years, and indoor residual spraying (IRS) in targeted districts, are the main pillars on which Benin’s National Malaria Control Programme (NMCP) relies for protection against malaria vectors. During the most recent mass distribution campaign in 2017, pyrethroid-treated LLINs (Yorkool, PermaNet 2.0 and Dawa Plus 2.0), were widely distributed across the country. In 2018, LLIN usage was relatively high, with 71% of the national population reporting sleeping under a net, and 92% of households owning at least one LLIN [1]. According to Bhatt et al., [2], malaria control interventions helped reduce malaria incidence by 40% in Africa between 2000 and 2015, with insecticide treated nets (ITNs) being the highest contributor (68% of cases averted). Similarly, reductions in malaria disease burden following the scale-up of LLINs have been routinely documented in trials conducted in several African countries including Kenya [3,4], and Benin [5,6]. Although LLINs are efficacious against susceptible vector populations, more recent studies have demonstrated that LLINs performed below expectations in areas where vectors are resistant to insecticides used for nets treatments, notably pyrethroids [7,8]. Insecticide resistance has emerged and spread across Africa, including Benin [9]. Between 2016 and 2018, progress in reducing malaria cases worldwide had stalled [9], with one of the likely reasons being pervasive insecticide resistance among malaria vector populations. Researchers and decision-makers now have high expectations of next generation LLINs which the World Health Organization (WHO) has encouraged manufacturers to develop for the control of resistant mosquitoes. Currently, next generation LLINs under evaluation include nets which combine a pyrethroid insecticide with either piperonyl butoxide (PBO; a synergist that inhibits mono-oxygenases implicated in resistance) or pyriproxyfen (PPF; a growth regulator that inhibits fecundity and fertility in insects) or chlorfenapyr (a pyrrole insecticide that disrupts mitochondrial oxidative phosphorylation). Cluster randomized controlled trials (RCTs) conducted in Tanzania [8], Uganda [10], and Burkina Faso [11] demonstrated that pyrethroid-PBO LLINs and pyrethroid-PPF LLINs provide more protection against malaria than standard LLINs. Other insecticide mixture LLINs combining alpha-cypermethrin and chlorfenapyr [12] or pyriproxyfen [13], have showed superior efficacy compared to standard LLINs on entomological outcomes in experimental hut trials. However, there remains a dearth of evidence regarding the effectiveness of the latter two dual-AI LLINs on malaria infection and transmission at the community-level. This study conducted in southern Benin presents baseline entomological data collected in preparation for an RCT assessing the effectiveness, of Interceptor G2 (a pyrethroid-chlorfenapyr LLIN) and Royal Guard (a pyrethroid-pyriproxifen LLIN) deployed in the community, on malaria incidence, prevalence and transmission.

Material and methods

Study area

The study was carried out in three adjacent districts [Covè (07˚13’08.0400” N, 02˚20’21.8400” E), Ouinhi (07°05′00″ N, 02°29′00″ E) and, Zagnanando (07°16′00″ N, 02°21′00″ E)] located 150 kilometers away from Cotonou, the economic capital of Benin. The area has two rainy seasons (May-July and September-November) and was selected because of its high endemicity for malaria, with infection prevalence of 36.5% in children aged under 5 years old [1], intense pyrethroid resistance in the primary malaria vector species [14] and proximity to experimental huts sites. The main economic activities carried out by the population are agriculture, fishing, hunting, trade, and hospitality industry. The main crops produced are groundnuts, rice, maize, oranges, cassava, beans, oil palm, sorghum and millet [15]. According to the study census performed in 2019, the area population was approximately 220,000. A total of 60 clusters were formed from the 123 villages in the study area. Entomological monitoring was conducted in one village in each cluster, equating to a total of 60 villages with 8 in Cove district, 33 in Zagnanando and 19 in Ouinhi (Fig 1).
Fig 1

Map of the study area.

Human landing catches (HLC)

Mosquito sampling technique

One round of mosquito collections was undertaken across villages, between September and October 2019. In each village, four houses were selected for mosquito sampling using HLCs. To facilitate the supervision of mosquito collectors for HLCs, the first house was randomly selected from the study census list, while the other three were chosen by the field team, within a radius of 15–20 meters around the first one. Four collectors were required per house. Two collectors (one indoor and one outdoor) collected mosquitoes during 6 hours from 07:00 p.m. to 01:00 a.m. and the second group from 01:00 to 07:00 a.m. The collectors sat on a chair with their lower limbs exposed and collected all mosquitoes which landed on them using sucking tubes. To characterize Anopheles biting behaviour, collections were recorded per hour both indoors and outdoors.

Mosquito processing

Mosquito specimens collected in HLCs were morphologically identified to species-level using the Gillies and Meillon [16] taxonomic key. In each village, a sub-sample of An. gambiae s.l. from indoor and outdoor collection and across collection hours were randomly selected, dissected to determine parous status [17], and analyzed by ELISA-CSP to detect presence of Plasmodium falciparum, following the protocol of Wirtz et al. [18]. Abdomens, legs and wings of An. gambiae s.l., previously analysed by ELISA-CSP, were used for species identification and L1014F kdr mutation following the protocols of Santolamazza et al. [19] and Martinez-Torres et al. [20], respectively.

Household data collection

A short questionnaire about LLIN use was administered in houses where HLCs were conducted using Open Data Kit (ODK). The questionnaire recorded information about number of inhabitants in the surveyed households, number of people sleeping indoors and outdoors, number of people sleeping under nets, type of house (mud, cement, others), type of nets presents in the house, condition of nets, GPS coordinates of households and, other malaria prevention measures (IRS, coils, any others) used by household members.

WHO susceptibility tube tests

Mosquito larvae collections and rearing

Mosquito larvae and pupae were sampled from various breeding sites in 2 nearby villages in each district, using a larval dipper. They were transported to the field insectary for rearing until adulthood at 25°C ± 2°C and 80% ± 10% relative humidity. After emergence, morphological identification of adult mosquitoes was performed to species-level, and only An. gambiae s.l. individuals were tested.

Susceptibility testing

In each district, batches of 20–25 unfed females An. gambiae s.l. aged 3–5 days old were aspirated into four tubes containing WHO insecticide impregnated papers (0.75% permethrin, 0.05% alpha-cypermethrin, 0.1% bendiocarb or 0.25% pirimiphos-methyl) for one hour. Separate batches were exposed to a tube lined with a WHO control paper in parallel. To evaluate the involvement of mixed function oxidases (MFOs) in pyrethroid resistance in populations of An. gambiae s.l., synergist assays with piperonyl butoxide (PBO; 4%) were performed. Mosquitoes were pre-exposed to PBO papers in WHO tubes for one hour, before transfer to different tubes with alpha-cypermethrin papers (0.05%) for a further hour. The percentage mortality at 24, 48, and 72 hours post-exposure was recorded. All tests were performed following the WHO protocol [21].

Ethical considerations

The protocol of the present study has been reviewed and approved by the Benin national ethics committee for health research (N°30/MS/DC/SGM/DRFMT/CNERS/SA, Approval n°6 of 04/03/2019) and the ethics committee at the London School of Hygiene and Tropical Medicine (16237–1). Written consent to participate in the study was taken from head of households and adult volunteers who performed HLCs after they have been fully informed of the risks of the study. Collectors were trained to collect any mosquito that landed on them before being bitten. All fieldworkers have been vaccinated against yellow fever. When they experienced malaria symptoms, they were immediately provided with anti-malarial medication such as Artemisinin-based Combination Therapy in the nearest health facility.

Data management and analysis

Entomological monitoring data were double entered into databases designed in CS Pro 7.2 software and, cleaned with Stata 15.0 (Stata Corp., College Station, TX). Entomological indicators of malaria transmission measured both indoors and outdoors, were determined as mentioned in the Table 1 below.
Table 1

Formulas of entomological indicators of malaria transmission.

IndicatorsFormulas
Human biting rate (HBR)Total An. gambiae s.l./number of collector night
Sporozoite rate (SR)Number of positive mosquitoes/Total number tested
Parous rateNumber of parous mosquitoes/Total number dissected
Monthly EIRHBR x SR x 30
As all An. gambiae s.l. positive for CSP ELISA and approximately 50% of the negative ones were tested for molecular species identification, the SR per molecular species (An. coluzzii and An. gambiae s.s.) was weighted to account for proportion of collected Anopheles processed for CSP. This allowed taking into account the unequal sampling. The mean of the household results for HBR, SR and EIR were used to generate a village level result. The mean of the village results is presented by district and their confidence intervals were calculated using the Poisson distribution. According to the WHO guidelines [21], resistance status of populations of An. gambiae s.l. was determined after exposure to the discriminating insecticide dose, as follows: Susceptible (mortality rate ≥ 98%) Possible resistance (mortality rate between 90–97%) Resistance (mortality <90%) According to the WHO guidelines [21], involvement of metabolic mechanisms in insecticide resistance in populations of An. gambiae s.l. was determined as follows: Metabolic mechanism not involved (insecticide-synergist mortality not higher than for insecticide-only) Metabolic mechanism partially involved (insecticide-synergist <98% mortality but higher than for insecticide-only) Metabolic mechanism fully involved (insecticide-synergist ≥98% and higher than for insecticide-only) Confidence intervals of mortality rates were determined using the exact binomial test. All statistical analyses were performed using Stata version 15.0 (Stata Corp., College Station, TX).

Results

Household and individual characteristics of study population

A total of 240 households were visited for HLCs, the average number of habitants per household was 4.5 (95% confidence interval (CI): 4.2–4.8) (Table 2). The majority (92.8%, 95% CI: 87.2–98.8) of the population slept indoors with no difference between districts. All visited households owned at least one LLIN. The proportion of people that report to sleep under nets the previous night was similar across districts with a mean of 82.7% (95% CI: 77.3–88.3) for the study area.
Table 2

Household and individual characteristics of study population.

IndicatorsCoveZangnanadoOuinhiStudy area
(95% CI), N(95% CI), N(95% CI), N(95% CI), N
Households (HH)
Total N of people699607373372596216289
Total N of HH16941184701873254143
N of visited HH3213276240
Mean N of people per visited HH4.3 (3.5–5.1), 1374.7 (4.3–5.1), 6244.4 (3.8–4.9), 3314.5 (4.2–4.8), 1092
Proportion of visited HH with at least one LLIN100%100%100%100%
People sleeping indoors in the visited HH97.1% (81.2–100), 13392.9% (85.5–100), 58090.9% (80.9–100), 30192.8% (87.2–98.8), 1014
People sleeping under nets the previous night in the visited HH89.1% (73.9–100), 12281.9% (74.9–89.3), 51181.6% (72.1–91.9), 27082.7% (77.3–88.3), 903
Type of housing
Cement wall40.6% (21.6–69.5), 1323.5% (15.9–33.3), 3126.3% (16.0–40.6), 2026.7% (20.5–34.1), 64
Mud wall43.8% (23.9–73.4), 1472% (58.2–87.9), 9564.5% (47.6–85.2), 4965.8% (55.9–76.9), 158
Other type of wall15.6% (5.0–36.5), 54.5% (1.6–9.9), 69.2% (3.7–18.9), 77.5% (4.4–11.9), 18
LLINs
Total number of LLINs62237148447
Mean N of LLINs per HH1.9 (1.4–2.5)1.8 (1.5–2.0)1.9 (1.6–2.3)1.9 (1.6–2.0)
Permanet 2.079% (58.4–100), 4988.6% (77.0–100), 21090.5 (75.8–100), 13487.9% (79.4–97.1), 393
Other LLINs21% (11.1–35.9), 1311.4% (7.5–16.6), 279.5 (5.1–15.9), 1412.1(9.8–15.8), 54
Holed nets45.2% (30–65.3), 2843.9% (35.8–53.2), 104 51.4 (40–64.3), 76 46.5% (40.4–53.3), 208

N: Number of, HH: Household.

N: Number of, HH: Household. Overall, the majority of houses were made of mud (65.8%, 95% CI: 55.9–76.9) and cement (26.7%, 95% CI: 20.5–34.1). At the district level, while most houses were made of mud in Zangnanando and Ouinhi, mud and cement made houses were found in similar proportions in the more urban district of Cove.The mean number of LLINs per household was 1.9 (95% CI: 1.6–2.0) in the study area and, similar across districts. The majority (87.9%, 95% CI: 79.4–97.1) of nets used were PermaNet 2.0. The other types of LLINs used were: OlysetNet, DawaPlus, DuraNet and Yorkool. On average, 46.5% (95% CI: 40.4–53.3) of LLINs had holes with no difference between districts (Table 2).

Mosquito species composition

A total of 46,613 mosquitoes were collected with HLCs. Culex and Mansonia accounted for 35.3% and 36.9% of all the collection respectively, and their proportions were slightly higher outdoors than indoors. An. gambiae s.l. was the most abundant of the Anopheles species and represented 28.2% and 18.4% of the collection indoors and outdoors respectively. Other species found in lower density were An. funestus, An. nili, An. ziemanni, and Aedes spp. collected both indoors and outdoors. Coquilletidia spp. and Eretmapodites spp. were captured only indoors but at very low frequencies (<1%) (Fig 2).
Fig 2

Mosquito species composition in the study area.

Molecular species identification performed on 1797 specimens showed that 53.9% (N = 968) were An. coluzzii and the remaining were An. gambiae s.s. Indoors, both species were in similar proportions [50.9%, 95% CI: 48.0–53.9 for An. coluzzii vs 49.1%, 95% CI: 46.1–52.0 for An. gambiae s.s.]. Outdoors, An. coluzzii predominated (59.3%, 95% CI: 55.3–63.1) over An. gambiae s.s. (40.7%, 95% CI: 36.8–44.7).

HBR, SR and monthly EIR in An. gambiae s.l.

Overall, the mean HBR was higher indoors with 26.5 bites per person per night (b/p/n) (95% CI: 25.2–27.9), n = 6373] compared to outdoors [18.5 b/p/n (95% CI: 17.4–19.6), n = 4434] in the study area. The same trend was observed in all three study districts (Table 3).
Table 3

HBR, SR and EIR in An. gambiae s.l. in Cove, Ouinhi and Zangnanado.

DistrictsBiting locationN of An collectedPerson nightHBR (95%CI)N of An testedSR (95%CI)EIR (95%CI)
CoveIndoor9753230.5a (26.7–34.6)3663.3a (0.6–9.5)21.4a (18.2–24.8)
Outdoor5563217.4b (14.6–20.5)1632.4a (0.06–13.4)6.4b (4.7–8.4)
ZangnanadoIndoor279213221.2a (19.6–22.8)11873.7a (1.8–6.5)24.1a (22.4–25.9)
Outdoor213413216.2b (14.8–17.6)7192.1a (0.5–5.4)5.9b (4.9–6.7)
OuinhiIndoor26067634.3a (31.7–37.1)7111.7a (0.3–4.9)17.3a (15.4–19.3)
Outdoor17447622.9b (20.8–25.2)4591.7a (0.2–6.3)4.3b (3.4–5.4)
Study areaIndoor637324026.5a (25.2–27.9)22642.9a (1.7–4.8)21.6a (20.4–22.8)
Outdoor443424018.5b (17.4–19.6)13411.8a (0.6–3.8)5.4b (4.8–6.0)

An: An. gambiae s.l., The SR is expressed in percentage (%), The HBR was expressed in the number of bites/person/night (b/p/n), The EIR is expressed in number of infected bites/person/month (ib/p/m)

a,b: Indicator values with different superscripts within a same district are significantly different (p<0.05).

An: An. gambiae s.l., The SR is expressed in percentage (%), The HBR was expressed in the number of bites/person/night (b/p/n), The EIR is expressed in number of infected bites/person/month (ib/p/m) a,b: Indicator values with different superscripts within a same district are significantly different (p<0.05). Biting of An. gambiae s.l. was more intense late at night both indoors and outdoors, with the lowest density before 10 pm. The peak in biting was 4.9 b/p/h (95% CI: 4.4–5.5) indoor and 3.3 b/p/h (95% CI: 2.9–3.8) outdoor and occurred between 4 and 6 a.m (Fig 3). The trend was the same at the study district level (Supporting information files, S1 Fig).
Fig 3

An. gambiae s.l. hourly biting rates in the study area (N = 6373 indoors, N = 4434 outdoors), b/p/h: Bite/person/hour, the error bars indicate the confidence intervals.

In An. gambiae s.l., the SR was higher indoors [2.9% (95% CI: 1.7–4.8), n = 2264] than outdoors [1.8% (95% CI: 0.6–3.8), n = 1341] in the study area with no significant difference, so was the trend in each district (Table 3). At the molecular species level, the SR was 3.1% (95% CI: 2.3–4.0) in An. gambiae s.s. compared to 2.1% (95% CI: 1.5–2.8) in An. coluzzii. Combined data revealed a higher monthly EIR indoors [21.6 b/p/m (95% CI: 20.4–22.8)] compared to outdoors [5.4 b/p/m (95% CI: 4.8–6.0)] in the study area, with the same trend in the three study districts (Table 3).

Parous rate in An. gambiae s.l.

Of the 2,843 specimens of An. gambiae s.l. dissected in the study area, 2,327 were parous equating to a parous rate of 81.6% (95% CI: 75.4–88.4). Similar parous rates were observed indoors (82.2%, 95% CI: 74.0–91.0) and outdoors (80.7%, 95% CI: 70.7–91.8) in the study area. The same trend was observed in all three study districts (Supporting information files, S1 Table).

WHO susceptibility tube tests and L1014F kdr mutation frequency

Susceptibility tube testing showed that An. gambiae s.l. populations were resistant to pyrethroid insecticides (alpha-cypermethrin and permethrin). By comparison, full susceptibility was observed to bendiocarb and pirimiphos-methyl. No significant difference was observed between the mortality rates at 24h, 48h and 72h, post-exposure (Fig 4) per district or per insecticide. While full susceptibility was not reached, pre-exposure to PBO increased mortality to alpha-cypermethrin from 9.6% (95% CI: 5.7–14.9), 4.5% (95% CI: 2–8.7), 8.6 (95% CI: 5.1–13.5) to 21.4% (95% CI: 15.7–28), 37.3% (95% CI: 30.5–44.5), 27.3% (95% CI: 17.7–38.6), respectively in Cove, Zangnanando and Ouinhi (Fig 5). This indicates partial involvement of mixed function oxidases (MFOs) in pyrethroid resistance in these An. gambiae s.l. populations.
Fig 4

Mortality rates of An. gambiae s.l. to 0.05% alpha-cypermethrin, 0.75% permethrin, 0.1% Bendiocarb and, 0.25% Pirimiphos-methyl, the error bars indicate the confidence intervals.

Fig 5

24 hours Mortality of An. gambiae s.l. to alpha-cypermethrin and PBO+alpha-cypermethrin in Cove, Ouinhi and Zangnanado, the error bars indicate the confidence intervals.

Frequency of the L1014F kdr mutation in An. gambiae s.s. was 89.8% (95% CI: 88.2–91.2, n = 829) compared to 84.3% (95% CI:82.5–85.9, n = 968) in An. coluzzii collected during HLC. At the district level, the same trend was observed in Zangnanando, while the frequency of the mutation was similar in both species in Cove and Ouinhi (Supporting information files, S2 Table).

Discussion

The current study provides detailed characteristics of vector populations in the study area in preparation for a cluster RCT which will assess the impact of community use of two dual-AI LLINs in the Zou region, Benin. Overall, Anopheles gambiae s.l. was the major vector complex, followed by Anopheles funestus and Anopheles nili, as previously reported in other regions of Benin [22-24]. Mosquito species from the Mansonia and Culex genera were also collected at moderate frequency (<40%), unlike Aedes, Coquilletidia and Eretmapodites which were found in low proportions (<2%). All collected mosquito species were found both indoors and outdoors except for Coquilletidia spp. and Eretmapodites spp. which were only collected indoors. The strong presence of mosquito species from the Culex and Aedes genera suggests a high potential for transmission of lymphatic filariasis and arbovirus such as dengue and yellow fever as observed in the Ouinhi [25] and Abomey-Calavi [26] districts. For that, apart from the LLINs whose distribution occurred as part of the RCT, a complementary strategy such as a larval source management program that will help discarding the majority of productive mosquito breeding sites would be needed. Molecular species identification performed within the An. gambiae s.l. complex revealed the presence of a mixture of An. coluzzii (53.9%) and An. gambiae s.s. (46.1%). This is consistent with results from previous studies carried out in the same area by Ngufor et al. [14] and, in the neighbouring Plateau region by Sovi et al. [27]. According to Diabate et al. [28], permanent and semi-permanent breeding sites are conducive to the development of An. coluzzii while, temporary breeding site are favorable to the emergence of An. gambiae s.s. Indeed, several semi-permanent breeding sites have been created by the numerous tributaries of the Oueme and Zou rivers that water the study area as well as the presence of many rice growing areas. By comparison, temporary breeding sites were usually created by rain. The variation observed in the composition of the two molecular species between indoor and outdoor suggests that a scrutiny survey investigating the host-seeking behaviour of each species would be of interest. Despite the large number of specimens of An. gambiae s.l. analysed by PCR, An. arabiensis was not detected, although its presence in the neighbouring districts of Allada has been documented [29]. This could be due to the short mosquito sampling period and, the zoophilic behaviour of this species. A large variability in the density of An. gambiae s.l. was observed among villages both indoors and outdoors in each district. This could be attributed to the disparity in the distribution of breeding sites from village to village. Despite the presence of LLINs in the majority of houses, and that more than 80% of household members slept under nets, the human biting rate in An. gambiae s.l was higher indoors than outdoors. This confirms the classical endophagic and anthropophagic behaviour which is observed in this mosquito species [30,31]. Indeed, this behaviour could have been facilitated by vector resistance to pyrethroids incorporated on the LLINs in use in the study area [14]. In addition, most biting was recorded late at night (from 11 p.m.), with peaks early in the early morning (around 4–5 a.m. or 5–6 a.m.). This suggests that the use of non-holed mosquito nets overnight can provide substantial protection to sleepers by significantly reducing the man-vector contact. According to a socio-anthropological study by N’tcha et al. [32], Benin’s rural populations usually perform various nightly activities (children’s play-activities, night talks, cooking, washing the dishes, eating, resting) outdoors and sleep under their nets indoors from 10 p.m. Thus, the little biting activity observed in An. gambiae s.l. early in the night (between 7-10pm) is not sufficient to put people at substantial elevated risk of receiving infected bites. Populations of An. gambiae s.l. from all three study districts were resistant to pyrethroids but fully susceptible to bendiocarb and pirimiphos-methyl. A similar trend was observed by Gnanguenon et al. [33] and Sovi et al. [34] in the neighbouring districts of Allada and Pobe/Ketou, respectively. High use of LLINs over years, as well as the uncontrolled spray of insecticides for agricultural purposes throughout the region might have contributed to vector resistance to pyrethroids. While emergence of bendiocarb resistance occurred in some northern regions of the country where a carbamate-based IRS was implemented [35,36], continued susceptibility to the same product and to pirimiphos-methyl was observed in the Cove, Ouinhi and, Zangnanando districts located in the south. This stresses the need for a judicious application of non-pyrethroid insecticides to delay the onset of resistance and preserve their efficacy. The resistance genotyping revealed that the high frequency of L1014 kdr mutation could be partly responsible for pyrethroid resistance in An. gambiae s.l. Indeed, the frequency was high at 89.8% in An. gambiae s.s. and 84.3% in An. coluzzii. In addition, the synergistic assay data suggests the partial involvement of MFOs that confer pyrethroid resistance, which confirms previous work performed in the region by Ngufor et al. [14]. Aggregated data in the study area shows a higher SR indoors than outdoors in An. gambiae s.l., although no significant difference was observed. This might be due to the difference in the molecular species composition between indoor and outdoor. Indeed, the relative high ability of An. gambiae s.s. to get infected could have increased the SR indoors where it was in similar proportion with An. coluzzii, contrary to outdoors where its proportion was significantly lower. Similarly, indoor biting vectors were slightly older as shown by the parity rates observed. This is reminiscent of works by Machani et al. [37] who observed similar trend for SR in Bungoma and Kisian, Western Kenya. Although not significant, the SR was higher in An. coluzzii than in An. gambiae s.s. in the Alibori and Donga regions, Northern Benin [38]. The opposite trend observed in the present study might indicate the relative time in the age structure of the mosquito population, since sampling was performed only once. The large variability in the EIR between villages confirms the heterogeneity in malaria transmission. Moreover, malaria transmission occurred mostly indoors than outdoors despite the use of conventional LLINs. This is in agreement with previous reports by Degefa et al. [39] in western Kenya, and might be due to the fact that most people slept indoors overnight and also the spread of resistance to pyrethroids incorporated in the conventional nets in use, as observed by Trape et al. [40] and, Ndiath et al. [41]. This emphasizes the need for assessing at the community level, the efficacy of dual-AI LLINs currently developed by the manufacturers, to control resistant mosquitoes. Outdoor malaria transmission is a well-documented phenomenon in several other countries, including Cambodia [42], Peru [43], and Kenya [36]. According to Sherrard-Smith et al. [44], with a scenario of universal LLIN and IRS coverage (indoor control tools) across Africa, outdoor transmission could result in an estimated 10.6 million additional malaria cases over a year. In future, a major challenge to malaria control and elimination will likely be residual transmission as it remains a serious threat to the effectiveness of vector control tools that mostly target indoor malaria transmission. Compared to An. gambiae s.l, An. funestus and An. nili likely play a minor role (lower EIR) in local malaria transmission due to their very low frequency (<2%), as observed in some Benin northern districts (Kerou and Pehunco) by Osse et al. [24]. However, the contribution of An. funestus and An. nili to malaria transmission was not evaluated in the present study. The seasonality and the single session of night sampling per village were also study limitations. High resistance of malaria vectors to pyrethroids, as well as persistence of the disease transmission despite the strong culture of conventional LLINs use make the study area suitable for the implementation of the RCT that aims at assessing the efficacy of two dual-AI LLINs on malaria incidence, prevalence and transmission. For this assessment, baseline data gathered over the present study will serve for comparisons with the post-intervention ones.

Conclusion

The present cross-sectional study provides information on key entomological indicators of malaria transmission prior to the implementation of the RCT. The mosquito relative abundance shows that An. gambiae s.l. was the primary malaria vector followed by An. funestus and An. nili. An. gambiae s.l. was both highly resistant to pyrethroids and displayed multiple resistance mechanisms, L1014F kdr mutation and mixed function oxidases. HBR and EIR were higher indoors than outdoors in An. gambiae s.l. despite the high usage of conventional LLINs. This stresses the need for evaluating novel types of dual-AI LLINs that could help to better tackle malaria transmitted by pyrethroid resistant vectors.

An. gambiae s.l. hourly biting rates in Cove, Zangnanado and Ouinhi.

(DOCX) Click here for additional data file.

Parous rate in An. gambiae s.l. in Cove, Ouinhi and Zangnanando.

(DOCX) Click here for additional data file.

Allelic frequencies of the L1014F kdr mutation in An. gambiae s.s and An. coluzzii collected using HLCs.

(DOCX) Click here for additional data file. 26 Apr 2021 PONE-D-21-02133 Pre-intervention characteristics of the mosquito species in Benin in preparation for a Randomized Controlled Trial assessing the efficacy of dual active-ingredient long-lasting insecticidal nets for controlling insecticide-resistant malaria vectors PLOS ONE Dear Dr. Sovi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 20, 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: Please clarify error bars on Figure 3,4 and 5 (CI or SEM?) and add in figure legend. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, John Vontas Academic Editor PLOS ONE Journal Requirements: 1) Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. 2) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 3) PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ 4) In your Methods, please provide more details about the participants consent, please clarify whether all the participants have been thoroughly informed of the risks of this study. In addition, please provide more details about what medical care/post treatment care was available for the participants, for example any precautions taken to try and protect fieldworkers from developing disease after infection, such as offering them antimalarial medication before being exposed to the mosquitoes. 5) Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Reviewer's report Title: Pre-intervention characteristics of the mosquito species in Benin in preparation for a Randomized Controlled Trial assessing the efficacy of dual active-ingredient long- lasting insecticidal nets for controlling insecticide-resistant malaria vectors General comments This study of Pre-intervention characteristics of the mosquito species in Benin in preparation for a Randomized Controlled Trial assessing the efficacy of dual active-ingredient long- lasting insecticidal nets for controlling insecticide-resistant malaria vectors represents an important topic related to the bionomics of malaria vectors and insecticide resistance. To study the entomological indicators in malaria vectors, human landing catch method is used. Prior this, informed consent was obtained from each collector. Moreover, the study protocol has been approved by the Benin national ethics committee for health research. I could recommend the current version of this paper for publication after the very minor additive data below. Version: 1 Date: 14 April 2021 Reviewer number: 1 Minor revisions • In 178 to 179, Indicate the geographical coordinates of each district (Covè, Ouinhi and, Zagnanando) in terms of longitude and latitude. • Indicate the North symbol/direction (N) of the compass on figure 1 legend (Map of study area) • Line 177 to 188: Authors should align the font of the paragraph similar to the rest text. • Authors could choose to underlined each paragraph titles or not. If so, then they need to do throughout the document. • Line 242 (Data management and analysis): Include in the table, the formulas for indoor and outdoor rates respectively. • HBR, SR and EIR in An. gambiae s.l. in Cove, Ouinhi and Zangnanado were reported. Have authors also stratified EIR data also according to the An. gambiae species (i.e EIR in An. coluzzii and An. gambiae s.s respectively)? It will be interesting if available to include in the manuscript. • Lines 304/305; 383/384: Because, Culex and Aedes represent the major mosquito's populations from the study area, authors should also discuss the strategies to reduce their effect on human, in the perspective of future LLINs trial, given the noising effect of Culex, and Aedes effect on human through dengue disease as described in many other countries. • Line 327/328: What the error bars mean on Figure 3? Is it confidence intervals (CI) or Standard error of means (SEM)? Please add in figure legend. • Line 367/368: What the error bars mean on Figure 4? Is it confidence intervals (CI) or Standard error of means (SEM)? Please add in figure legend. • Line 369/370: What the error bars mean on Figure 5? Is it confidence intervals (CI) or Standard error of means (SEM)? Please add in figure legend • Line 580 to 581: Please check for line spacing and homogenise accordingly Level of interest: Statistical analysis added using Stata Level of interest: An article of importance in its field Quality of written English: Acceptable ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. Submitted filename: Report PONE-D-21-02133_reviewer.pdf Click here for additional data file. 30 Apr 2021 All authors have agreed to changes made according to the comments from the reviewer and the editor. Reviewer 1 1- In 178 to 179, Indicate the geographical coordinates of each district (Covè, Ouinhi and, Zagnanando) in terms of longitude and latitude. Response: Done. See lines 178 & 179 2- Indicate the North symbol/direction (N) of the compass on figure 1 legend (Map of study area) Response: Done. See the legend on figure 1 3- Line 177 to 188: Authors should align the font of the paragraph similar to the rest text. Response: Corrected 4-Authors could choose to underlined each paragraph titles or not. If so, then they need to do throughout the document. Response: We have now chosen not to underline anymore the paragraph titles and have been consistent throughout the test. 5- Line 242 (Data management and analysis): Include in the table, the formulas for indoor and outdoor rates respectively. Response: For all calculated entomological indicators, the formulas used, were the same for both indoors and outdoors (See lines 259 & 260). 6- HBR, SR and EIR in An. gambiae s.l. in Cove, Ouinhi and Zangnanado were reported. Have authors also stratified EIR data also according to the An. gambiae species (i.e EIR in An. coluzzii and An. gambiae s.s. respectively)? It will be interesting if available to include in the manuscript. Response: We agree with you that it would be interesting to include the EIR of An. gambiae s.s. and An. coluzzii in the manuscript, however we think that it may not show the real trend in terms of contribution of each molecular species to malaria transmission in the study area, given that only a sub-sample of collected specimens of An. gambiae s.l. have been tested through PCR for molecular species identification. 7- Lines 304/305; 383/384: Because, Culex and Aedes represent the major mosquito's populations from the study area, authors should also discuss the strategies to reduce their effect on human, in the perspective of future LLINs trial, given the noising effect of Culex, and Aedes effect on human through dengue disease as described in many other countries. Response: This is now discussed (See the discussion, from line 400 to line 406) 8- Line 327/328: What the error bars mean on Figure 3? Is it confidence intervals (CI) or Standard error of means (SEM)? Please add in figure legend. Response: The error bars on Figure 3 are the confidence intervals, see lines 341/342. 9-Line 367/368: What the error bars mean on Figure 4? Is it confidence intervals (CI) or Standard error of means (SEM)? Please add in figure legend. Response: The error bars on Figure 4 are the confidence intervals, see lines 381/382. 10-Line 369/370: What the error bars mean on Figure 5? Is it confidence intervals (CI) or Standard error of means (SEM)? Please add in figure legend Response: The error bars on Figure 5 are the confidence intervals, see lines 383/384. 11-Line 580 to 581: Please check for line spacing and homogenise accordingly Response: Corrected Journal Requirements: 1-Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Response: The reference list is complete and correct. No retracted article has been cited. 2-Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming Response: The manuscript fully meets PLOS ONE's style requirements 3-PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ Response: Done 4-In your Methods, please provide more details about the participants consent, please clarify whether all the participants have been thoroughly informed of the risks of this study. In addition, please provide more details about what medical care/post treatment care was available for the participants, for example any precautions taken to try and protect fieldworkers from developing disease after infection, such as offering them antimalarial medication before being exposed to the mosquitoes. Response: See the ethical consideration section (From line 244 to 253) 5-Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. Response: Done We think that we have taken into account the recommendations and hope that the manuscript will be published soon. Many thanks Submitted filename: Response to reviewers.docx Click here for additional data file. 3 May 2021 Pre-intervention characteristics of the mosquito species in Benin in preparation for a Randomized Controlled Trial assessing the efficacy of dual active-ingredient long-lasting insecticidal nets for controlling insecticide-resistant malaria vectors PONE-D-21-02133R1 Dear Dr. ARTHUR SOVI, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, John Vontas Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: 12 May 2021 PONE-D-21-02133R1 Pre-intervention characteristics of the mosquito species in Benin in preparation for a Randomized Controlled Trial assessing the efficacy of dual active-ingredient long-lasting insecticidal nets for controlling insecticide-resistant malaria vectors Dear Dr. Sovi: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. John Vontas Academic Editor PLOS ONE
  38 in total

1.  Molecular characterization of pyrethroid knockdown resistance (kdr) in the major malaria vector Anopheles gambiae s.s.

Authors:  D Martinez-Torres; F Chandre; M S Williamson; F Darriet; J B Bergé; A L Devonshire; P Guillet; N Pasteur; D Pauron
Journal:  Insect Mol Biol       Date:  1998-05       Impact factor: 3.585

2.  Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development.

Authors:  R A Wirtz; F Zavala; Y Charoenvit; G H Campbell; T R Burkot; I Schneider; K M Esser; R L Beaudoin; R G Andre
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

3.  Malaria vectors resistance to insecticides in Benin: current trends and mechanisms involved.

Authors:  Virgile Gnanguenon; Fiacre R Agossa; Kefilath Badirou; Renaud Govoetchan; Rodrigue Anagonou; Fredéric Oke-Agbo; Roseric Azondekon; Ramziath AgbanrinYoussouf; Roseline Attolou; Filemon T Tokponnon; Rock Aïkpon; Razaki Ossè; Martin C Akogbeto
Journal:  Parasit Vectors       Date:  2015-04-12       Impact factor: 3.876

4.  The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015.

Authors:  S Bhatt; D J Weiss; E Cameron; D Bisanzio; B Mappin; U Dalrymple; K Battle; C L Moyes; A Henry; P A Eckhoff; E A Wenger; O Briët; M A Penny; T A Smith; A Bennett; J Yukich; T P Eisele; J T Griffin; C A Fergus; M Lynch; F Lindgren; J M Cohen; C L J Murray; D L Smith; S I Hay; R E Cibulskis; P W Gething
Journal:  Nature       Date:  2015-09-16       Impact factor: 49.962

5.  Insecticide-treated nets provide protection against malaria to children in an area of insecticide resistance in Southern Benin.

Authors:  John Bradley; Aurore Ogouyèmi-Hounto; Sylvie Cornélie; Jacob Fassinou; Yolande Sissinto Savi de Tove; Adicath Adéola Adéothy; Filémon T Tokponnon; Patrick Makoutode; Alioun Adechoubou; Thibaut Legba; Telesphore Houansou; Dorothée Kinde-Gazard; Martin C Akogbeto; Achille Massougbodji; Tessa Bellamy Knox; Martin Donnelly; Immo Kleinschmidt
Journal:  Malar J       Date:  2017-05-26       Impact factor: 2.979

6.  Insecticide-Treated Nets and Protection against Insecticide-Resistant Malaria Vectors in Western Kenya.

Authors:  Eric Ochomo; Mercy Chahilu; Jackie Cook; Teresa Kinyari; Nabie M Bayoh; Philippa West; Luna Kamau; Aggrey Osangale; Maurice Ombok; Kiambo Njagi; Evan Mathenge; Lawrence Muthami; Krishanthi Subramaniam; Tessa Knox; Abraham Mnavaza; Martin James Donnelly; Immo Kleinschmidt; Charles Mbogo
Journal:  Emerg Infect Dis       Date:  2017-05       Impact factor: 6.883

7.  Entomological assessment of the risk of dengue outbreak in Abomey-Calavi Commune, Benin.

Authors:  Germain Gil Padonou; Razaki Ossè; Albert Sourou Salako; Rock Aikpon; Arthur Sovi; Casimir Kpanou; Hermann Sagbohan; Yessoufou Akadiri; Baba-Moussa Lamine; Martin C Akogbeto
Journal:  Trop Med Health       Date:  2020-04-10

8.  Insertion polymorphisms of SINE200 retrotransposons within speciation islands of Anopheles gambiae molecular forms.

Authors:  Federica Santolamazza; Emiliano Mancini; Frédéric Simard; Yumin Qi; Zhijian Tu; Alessandra della Torre
Journal:  Malar J       Date:  2008-08-25       Impact factor: 2.979

9.  Indoor and outdoor malaria vector surveillance in western Kenya: implications for better understanding of residual transmission.

Authors:  Teshome Degefa; Delenasaw Yewhalaw; Guofa Zhou; Ming-Chieh Lee; Harrysone Atieli; Andrew K Githeko; Guiyun Yan
Journal:  Malar J       Date:  2017-11-06       Impact factor: 2.979

10.  Efficacy of Royal Guard, a new alpha-cypermethrin and pyriproxyfen treated mosquito net, against pyrethroid-resistant malaria vectors.

Authors:  Corine Ngufor; Abel Agbevo; Josias Fagbohoun; Augustin Fongnikin; Mark Rowland
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

View more
  1 in total

1.  Malaria Burden and Associated Risk Factors in an Area of Pyrethroid-Resistant Vectors in Southern Benin.

Authors:  Manfred Accrombessi; Martin C Akogbeto; Edouard Dangbenon; Hilaire Akpovi; Arthur Sovi; Boulais Yovogan; Constantin Adoha; Landry Assongba; Aurore Ogouyemi-Hounto; Germain Gil Padonou; Charles Thickstun; Mark Rowland; Corine Ngufor; Natacha Protopopoff; Jackie Cook
Journal:  Am J Trop Med Hyg       Date:  2022-07-18       Impact factor: 3.707

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.